CAACB News & Events
News
|
The CBI’s Consortium on Adventitious Agent Contamination in Biopharmaceutical Manufacturing featured in Nature editorial. (April 28, 2011) A recent Nature editorial discusses the problem of viral contamination in biopharmaceutical manufacturing. The editorial highlights the work being done at MIT, through the CAACB, and the potential positive impact on the biopharmaceutical industry. More Info. |
| MIT CBI launches new biopharmaceutical manufacturing industry initiative to tackle adventitious agent contamination. (January 1, 2011) The MIT Center for Biomedical Innovation has launched a new industrial initiative, the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), beginning to address an industry-wide problem. With vital industry participation, the CAACB will collect, analyze and share industry risks and prevention strategies regarding adventitious agent contamination. |
| CAACB initiative to be presented at the PDA’s Virus and TSE Safety Forum in Barcelona. (June 28-30, 2010) Dr. Houman Dehghani, of Amgen, will give the presentation “Maximize the Knowledge of Past Virus Contamination Events to Benefit the Future – An MIT-led and Industry-Sponsored Project” about the CAACB initiative at the PDA’s Virus and TSE Safety Forum in Barcelona. |
Events
| December 1, 2010 | Dr. Michael Wiebe presented “Industry Consortium on Adventitious Agent Contamination in Biomanufacturing” at the PDA/FDA workshop on Adventitious Viruses in Biologics: Detection and Mitigation Strategies |
| November 17, 2010 | CAACB initiative presented at BioMAN Summit “Science to Manage Risk in Biomanufacturing” |
| November 17, 2010 | Consortium on Adventitious Agent Contamination in Biomanufacturing Kick-off Meeting |